Journey Medical Corporation公布了评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果,结果已刊登在《皮肤病药物杂志》上。
Journey Medical Corporation公布了评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果,结果已刊登在《皮肤病药物杂志》上。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.